Type 1 diabetics should continue any basal insulin during dietary preparation and try to minimize fast-acting insulin products during the diet if it is believed safe for the patient. Sliding-scale, ...

Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with diabetes, reducing the number of injections needed, has hit a major hurdle in the US. The FDA sent the Danish ...

Novo Nordisk said that if approved for use, insulin icodec would reduce the number of basal insulin injections needed per year for type 2 diabetics from 365 to 52, a significant reduction in ...

Small molecules with big potential The two drugs used in this study are already approved to treat rare cancers. Tazemetostat, known under the brand name Tazverik, was approved by the U.S. FDA in ...

In most trials, patients were randomized to receive insulin on three different dosing schedules: basal insulin twice daily before breakfast and at bedtime, basal insulin at 12-hour intervals ...

Novo Nordisk’s insulin brand Mixtard will continue to be available in vials, the Danish healthcare company clarified, even as it phases out its penfill. The penfill is being phased out as part ...

By Michael D. Shear Reporting from London Seven pediatric doctors and toxicology experts said on Thursday that jurors were misled by prosecutors who cited unreliable insulin tests during the trial ...

Inhaled insulin is a drug you breathe into your lungs to help control your blood sugar and diabetes. It comes in the form of an inhaler. "Inhaled insulin comes as a powder and has a component that ...

The board voted to add their name to a lawsuit alleging that insulin is unfairly overpriced in the United States at their March 18 meeting. If successful, the suit could result in a payout of ...

Backed by companies like Nvidia Corp. NVDA, Amazon.com Inc. AMZN, and Meta Platforms Inc. META, Scale AI is reportedly seeking a valuation of up to $25 billion in a new tender offer. What Happened ...

According to Ahn, “As of now, not all commercial insurance plans are covering CGM for basal insulin only users, which Medicare now covers, but the requirements for coverage are slowly loosening ...